REZLIFTY
Live / Allowed — Notice of allowance issued (as of 07 Oct 2025)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Jan 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 98961219
- Mark type
- Stylized text
- Filed
- 14 Jan 2025
- Published for opposition
- 12 Aug 2025
- Attorney of record
- Deborah L. Corpus
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for treating anaphylaxis; pharmaceutical preparations exhibiting vasoconstricting, intraocular pressure-reducing, and bronchodilating activities, namely, pharmaceutical preparations for treating low blood pressure, intraocular pressure and broncho-constriction
Owner
- Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ, US
- Hikma Pharmaceuticals USA Inc., Berkeley Heights, NJ, US
Prosecution history
- 07 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 12 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 12 Aug 2025 — PUBLISHED FOR OPPOSITION
- 06 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 24 Jun 2025 — ASSIGNED TO EXAMINER
- 14 Jan 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 14 Jan 2025 — APPLICATION FILING RECEIPT MAILED
- 14 Jan 2025 — NEW APPLICATION ENTERED